A Less Restrictive Policy for Liver Transplantation in Coronavirus Disease 2019 Positive Patients, Based Upon Cycle Threshold Values

por Raveh, Yehuda, Simkins, Jacques, Vianna, Rodrigo, Tekin, Akin, Nicolau-Raducu, Ramona
Publicado 2021

Liver transplantation as a novel strategy for resolution of congenital afibrinogenemia in a pediatric patient

por Corrales‐Medina, Fernando F., Miloh, Tamir, O’Farrell, Candelaria, Andrews, David M., Tekin, Akin, De Angulo, Guillermo
Publicado 2020

Liver Inclusion Appears to Be Protective Against Graft Loss-Due-to Chronic But Not Acute Rejection Following Intestinal Transplantation

por Vianna, Rodrigo, Gaynor, Jeffrey J., Selvaggi, Gennaro, Farag, Ahmed, Garcia, Jennifer, Tekin, Akin, Tabbara, Marina M., Ciancio, Gaetano
Publicado 2023

No Benefit of Prophylactic Surgical Drainage in Combined Liver and Kidney Transplantation: Our Experience and Review of the Literature

por Vincenzi, Paolo, Gaynor, Jeffrey J., Chen, Linda J., Figueiro, Jose, Morsi, Mahmoud, Selvaggi, Gennaro, Tekin, Akin, Vianna, Rodrigo, Ciancio, Gaetano
Publicado 2021

Propylthiouracil-Induced Acute Liver Failure: Role of Liver Transplantation

por Carrion, Andres F., Czul, Frank, Arosemena, Leopoldo R., Selvaggi, Gennaro, Garcia, Monica T., Tekin, Akin, Tzakis, Andreas G., Martin, Paul, Ghanta, Ravi K.
Publicado 2010

Cell-Free DNA as a Surveillance Tool for Hepatocellular Carcinoma Patients after Liver Transplant

por Manzi, Joao, Hoff, Camilla O., Ferreira, Raphaella, Glehn-Ponsirenas, Renata, Selvaggi, Gennaro, Tekin, Akin, O’Brien, Christopher B., Feun, Lynn, Vianna, Rodrigo, Abreu, Phillipe
Publicado 2023

CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment

por Hotta, Ryuichi, Ohira, Masahiro, Matsuura, Toshiharu, Muraoka, Izumi, Tryphonopoulos, Panagiotis, Fan, Ji, Tekin, Akin, Selvaggi, Gennaro, Levi, David, Ruiz, Phillip, Ricordi, Camillo, Vianna, Rodrigo, Ohdan, Hideki, Waldmann, Herman, Tzakis, Andreas G., Nishida, Seigo
Publicado 2016

Host microRNAs are decreased in pediatric solid-organ transplant recipients during EBV+ Post-transplant Lymphoproliferative Disorder

por Sen, Ayantika, Enriquez, Jeanna, Rao, Mahil, Glass, Marla, Balachandran, Yarl, Syed, Sharjeel, Twist, Clare J., Weinberg, Kenneth, Boyd, Scott D., Bernstein, Daniel, Trickey, Amber W., Gratzinger, Dita, Tan, Brent, Lapasaran, Mary Gay, Robien, Mark A., Brown, Merideth, Armstrong, Brian, Desai, Dev, Mazariegos, George, Chin, Clifford, Fishbein, Thomas M., Venick, Robert S., Tekin, Akin, Zimmermann, Heiner, Trappe, Ralf U., Anagnostopoulos, Ioannis, Esquivel, Carlos O., Martinez, Olivia M., Krams, Sheri M.
Publicado 2022